These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
296 related articles for article (PubMed ID: 27073590)
1. SIRT1: A Novel Target for the Treatment of Muscular Dystrophies. Kuno A; Horio Y Oxid Med Cell Longev; 2016; 2016():6714686. PubMed ID: 27073590 [TBL] [Abstract][Full Text] [Related]
2. Resveratrol ameliorates muscular pathology in the dystrophic mdx mouse, a model for Duchenne muscular dystrophy. Hori YS; Kuno A; Hosoda R; Tanno M; Miura T; Shimamoto K; Horio Y J Pharmacol Exp Ther; 2011 Sep; 338(3):784-94. PubMed ID: 21652783 [TBL] [Abstract][Full Text] [Related]
3. Therapeutic potential of PEGylated insulin-like growth factor I for skeletal muscle disease evaluated in two murine models of muscular dystrophy. Gehrig SM; van der Poel C; Hoeflich A; Naim T; Lynch GS; Metzger F Growth Horm IGF Res; 2012 Apr; 22(2):69-75. PubMed ID: 22424862 [TBL] [Abstract][Full Text] [Related]
4. The effects of resveratrol and SIRT1 activation on dystrophic cardiomyopathy. Kuno A; Tanno M; Horio Y Ann N Y Acad Sci; 2015 Aug; 1348(1):46-54. PubMed ID: 26109180 [TBL] [Abstract][Full Text] [Related]
5. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy. Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351 [TBL] [Abstract][Full Text] [Related]
6. P2RX7 purinoceptor: a therapeutic target for ameliorating the symptoms of duchenne muscular dystrophy. Sinadinos A; Young CN; Al-Khalidi R; Teti A; Kalinski P; Mohamad S; Floriot L; Henry T; Tozzi G; Jiang T; Wurtz O; Lefebvre A; Shugay M; Tong J; Vaudry D; Arkle S; doRego JC; Górecki DC PLoS Med; 2015 Oct; 12(10):e1001888. PubMed ID: 26461208 [TBL] [Abstract][Full Text] [Related]
7. A new therapeutic effect of simvastatin revealed by functional improvement in muscular dystrophy. Whitehead NP; Kim MJ; Bible KL; Adams ME; Froehner SC Proc Natl Acad Sci U S A; 2015 Oct; 112(41):12864-9. PubMed ID: 26417069 [TBL] [Abstract][Full Text] [Related]
8. The role of free radicals in the pathophysiology of muscular dystrophy. Tidball JG; Wehling-Henricks M J Appl Physiol (1985); 2007 Apr; 102(4):1677-86. PubMed ID: 17095633 [TBL] [Abstract][Full Text] [Related]
9. A Systematic Review on the Role of SIRT1 in Duchenne Muscular Dystrophy. Domi E; Hoxha M; Prendi E; Zappacosta B Cells; 2021 Jun; 10(6):. PubMed ID: 34205021 [TBL] [Abstract][Full Text] [Related]
10. A new model of experimental fibrosis in hindlimb skeletal muscle of adult mdx mouse mimicking muscular dystrophy. Desguerre I; Arnold L; Vignaud A; Cuvellier S; Yacoub-Youssef H; Gherardi RK; Chelly J; Chretien F; Mounier R; Ferry A; Chazaud B Muscle Nerve; 2012 Jun; 45(6):803-14. PubMed ID: 22581532 [TBL] [Abstract][Full Text] [Related]
11. [Molecular therapy of muscular dystrophy]. Takeda S Rinsho Shinkeigaku; 2000 Dec; 40(12):1267-9. PubMed ID: 11464475 [TBL] [Abstract][Full Text] [Related]
12. NAD+ repletion improves muscle function in muscular dystrophy and counters global PARylation. Ryu D; Zhang H; Ropelle ER; Sorrentino V; Mázala DA; Mouchiroud L; Marshall PL; Campbell MD; Ali AS; Knowels GM; Bellemin S; Iyer SR; Wang X; Gariani K; Sauve AA; Cantó C; Conley KE; Walter L; Lovering RM; Chin ER; Jasmin BJ; Marcinek DJ; Menzies KJ; Auwerx J Sci Transl Med; 2016 Oct; 8(361):361ra139. PubMed ID: 27798264 [TBL] [Abstract][Full Text] [Related]
13. Targeted disruption of exon 52 in the mouse dystrophin gene induced muscle degeneration similar to that observed in Duchenne muscular dystrophy. Araki E; Nakamura K; Nakao K; Kameya S; Kobayashi O; Nonaka I; Kobayashi T; Katsuki M Biochem Biophys Res Commun; 1997 Sep; 238(2):492-7. PubMed ID: 9299538 [TBL] [Abstract][Full Text] [Related]
14. Oxidative stress and pathology in muscular dystrophies: focus on protein thiol oxidation and dysferlinopathies. Terrill JR; Radley-Crabb HG; Iwasaki T; Lemckert FA; Arthur PG; Grounds MD FEBS J; 2013 Sep; 280(17):4149-64. PubMed ID: 23332128 [TBL] [Abstract][Full Text] [Related]